Hanny Al-Samkari, M.D. is a classical hematologist and leading international clinical investigator in hemostasis, platelet disorders, and hemolytic anemias. His focus is on the development of novel therapeutics in hereditary hemorrhagic telangiectasia, immune thrombocytopenia, chemotherapy-induced thrombocytopenia and hemolytic anemia. He serves as global principal investigator for many ongoing studies in these areas.

Dr. Hind Abdin Ahmed Salama is a consultant adult hematologist at King Abdulaziz Medical City, Riyadh, and Assistant Professor at King Saud bin Abdulaziz University for Health Sciences. She earned her MBBS from Gezira University, Sudan, MRCP-UK, and completed an SFH hematology and bone marrow transplant fellowship. She leads acute lymphoblastic leukemia and adult histiocytic clinics and initiated the first adult histiocytic clinic in Saudi Arabia. Dr. Salama has 46 publications, received multiple national and international research awards, and was recognized by the ECD Global Alliance as a referral expert and center.